Long-Term Voclosporin Treatment in Adolescent and Pediatric Subjects With Lupus Nephritis
Status:
ENROLLING_BY_INVITATION
Trial end date:
2029-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the long-term safety and tolerability of voclosporin for up to an additional 12 months following completion of treatment in the AUR-VCS-2020-03 study (VOCAL) in adolescent and pediatric subjects with lupus nephritis.